null

Anti-CTLA-4 (Tremelimumab biosimilar) mAb (HDBS0754)

SKU:
HDBS0754
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Inflammatory Response Assays
Pharmacokinetics
Disease Area:
Cancer Immunotherapy
Disease Area:
Autoimmune Diseases
Size:
100 μg
Target:
CTLA-4
Isotype:
IgG2
Host Species:
Whole mAb
Reactivity:
Human
€429

Description

system_update_altDatasheetsystem_update_altMSDS
Product Name:Anti-CTLA-4 (Tremelimumab biosimilar) mAb
SKU:HDBS0754
Size:100 μg
Target:CTLA-4
Common Name:CP-675;CP675;CP 675;CP-675206;CP 675206;CP675206;IMJUDO;Ticilimumab
Isotype:IgG2
Host Species:Whole mAb
Reactivity:Human
Synonyms:CD;GSE;GRD4;ALPS5;CD152;CTLA-4;IDDM12;CELIAC3
Conjugate:Unconjugated

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Uniprot:P16410
Formulation & Reconstitution:Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Usage:Research use only
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Related Products